---
figid: PMC9056507__41419_2022_4881_Fig6_HTML
pmcid: PMC9056507
image_filename: 41419_2022_4881_Fig6_HTML.jpg
figure_link: /pmc/articles/PMC9056507/figure/Fig6/
number: Fig. 6
figure_title: Inhibition of TAK1 attenuates the exaggerated hypertrophic effect of
  GCN5 overexpression
caption: 'A–C Effects of iTAK1 on EF, FS, and LVESd values in GCN5-overexpressing
  mice and control mice after sham or TAC surgery (n = 6–7 mice/group). D–F Effects
  of iTAK1 on HW/BW, HW/TL, and LW/BW ratios in GCN5-overexpressing mice and control
  mice after sham or TAC surgery (n = 6–7 mice/group). G iTAK1-induced histological
  changes in heart sections stained with H&E and WGA to analyze heart and cardiomyocyte
  size, respectively. (n = 6-7 mice/group). H iTAK1-induced histological changes in
  heart sections stained with Masson’s trichrome stain to analyze perivascular and
  interstitial fibrotic area (n = 6–7 mice/group, ∗P < 0.05, ∗∗P < 0.01 vs AAV9-Vector
  TAC 4 W, ##P < 0.01 vs AAV9-GCN5 TAC 4 W).'
article_title: GCN5-mediated regulation of pathological cardiac hypertrophy via activation
  of the TAK1-JNK/p38 signaling pathway.
citation: Jia Li, et al. Cell Death Dis. 2022 Apr;13(4):421.
year: '2022'

doi: 10.1038/s41419-022-04881-y
journal_title: Cell Death & Disease
journal_nlm_ta: Cell Death Dis
publisher_name: Nature Publishing Group UK

keywords:
- Heart failure
- Cell signalling

---
